Efficacy and safety of intracoronary versus intravenous tirofiban in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: A meta-analysis of randomized controlled trials

Efficacy and safety of intracoronary versus intravenous tirofiban in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: A meta-analysis of randomized controlled trials

Background: Effective antiplatelet therapy is critical for patients with ST-segment elevation myocardial infarction (STEMI) and receiving primary percutaneous coronary interventions (PPCI). Intracoronary (IC) and intravenous (IV) administration of tirofiban are commonly used during the procedure of...

Full description

Bibliographic Details
Main Authors: Rui Tian, Rugang Liu, Jiajun Zhang, Yong Li, Shujian Wei, Feng Xu, Xiaoxing Li, Chuanbao Li
Format: Article
Language:English
Published: Elsevier 2023-05-01
Series:Heliyon
Subjects:
ST-elevation myocardial infarction
Percutaneous coronary intervention
Tirofiban
Meta-analysis
Randomized controlled trial
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844023030499

Internet

http://www.sciencedirect.com/science/article/pii/S2405844023030499

Similar Items